到 2031 年门诊中央履行市场的增长和规模

Publication Month : Jan 2024

  • Report Code : TIPRE00037800
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 149
Inquire Before Buy

PRICING

$5190

$4152

【研究报告】门诊中央履行市场规模预计将从2022年的3.0932亿美元激增至2030年的7.2579亿美元;预计 2022 年至 2030 年市场复合年增长率为 11.3%。

分析师观点:

自动化任何制药流程的机械程序通常需要跟踪和更新数据库中的客户信息(例如,病史和药物相互作用风险检测),计数小物体(例如,药丸和胶囊),以及测量和组合粉末和液体以进行编译和其他此类活动。因此,自动化药房受到许多医院和药店的青睐。医院利用药房自动化来改善患者护理并实现长期财务节省。例如,医院药房自动执行测量液体或粉末进行混合的任务,以简化和自动化医疗保健药物处理。在全球药房中集成自动化服务显着提高了处方药的储存、配药、灌装、包装和标签的有效性和安全性。此外,填写和贴标签处方会产生药物浪费;通过药房自动化可以最大限度地减少这种浪费。因此,传统药店也开始向自动化系统转型。因此,这些因素预计将影响全球门诊中央履行市场的增长。

市场概述:

由于消费者对药品的需求增加、竞争更加激烈,药房自动化行业正在增长。制药公司之间的技术进步和精确的机器人设备可用性。对无差错药品的需求不断增长预计将推动门诊中央履行市场。许多国家的政府正在药房和医院推广自动化用药技术,以减少处方和配药错误。因此,门诊集中履行越来越受欢迎。然而,医疗机构不愿支持门诊集中处理可能会在一定程度上阻碍整体市场的增长。严格的监管控制和大量的初始投资要求也限制了门诊中央履行市场的增长。

主要参与者的技术进步有利于门诊中央履行市场的增长。 2021 年 9 月,Deenova 报告在德国赢得了第一份合同,并同时在欧洲最大的 GDP 医疗保健市场建立了 Deenova 业务。根据这份合同,该公司将在盖尔森基兴 Marien 医院交付并安装 3 台一体式包装机器人、34 台一体式配药机器人和 72 辆经过安全床边验证的一体式手推车。它还将为这些解决方案提供全方位服务支持。 Marien Hospital Gelsenkirchen 是 St. Augustinus Gelsenkirchen GmbH 服务网络中的一家运营公司。

战略见解

市场驱动力和约束:

药房自动化已成为医疗自动化领域之一医疗保健行业最繁荣的部分。自动化技术可以通过自动化药房任务和流程来改善患者护理并提高效率。 Visionary Insights 的一项研究表明,到 2021 年,药房的自动化程度预计将增加 22%。这种增长可能是由于对精确、高效配药的需求不断增长,以及专业药物配药操作数量的增加。药剂师还采用技术来自动化配药以外的某些其他任务,例如库存管理。自动化库存系统可以帮助药房更准确地跟踪和管理库存,预计这将促进门诊中央履行市场的增长。

2021 年 2 月,Omnicell Inc. 宣布推出下一代 Medimat ,零售药店的自动配药系统。它的建立是为了提高患者安全、有效利用时间和节省资金。同样,innovativeAspirations (iA) 是一家软件支持的药房履行和自动化解决方案商业提供商,于 2021 年 8 月推出了 3 个与 Medimat 的 NEXiA 技术集成的解决方案,以集中管理处方药的履行。 iA 还推出了 SmartPod,这是一款带有模块化自动填充单元的下一代机器人。市场参与者的此类策略预计将推动门诊中央履行市场。

可能伤害患者的常见用药错误包括配发错误的药物、药物数量不正确以及药物强度错误。此外,无意中遗漏项目可能会导致用药错误。这些错误令人震惊,被认为是全球第三大死亡原因。世界卫生组织(WHO)还表示,用药错误导致全球100万人口中有1人死亡。不安全的医疗实践给医疗保健行业带来了不可避免的风险。据美国食品和药物管理局 (FDA) 称,每年收到超过 100,000 份与用药错误相关的报告。分心是用药错误的主要原因。出现分心的原因是医疗保健专业人员全天从事多项任务,包括检查患者、与顾问互动、与患者家属交谈以及与保险专业人员交谈。有时,急于完成职责时会出现判断失误,这可能会导致用药错误。用药错误的另一个主要原因是失真。糟糕的书写、缩写、误解的符号或不正确的翻译都会导致扭曲。因此,不可否认,用药错误的可能性推动了门诊中央履行市场的增长。

尽管自动化在药房运营中具有明显的好处,但医生和医疗保健提供者对其采用仍存在阻力。这种不情愿主要是由于文化障碍,特别是在新兴市场。自动化药房主要受到高能力药剂师和医疗机构的欢迎,它们可以通过实施此类自动化系统实现投资回报 (ROI) 的合理化。据 Rangewell 称,药房自动化成本从 54,710.50 美元到 547,105 美元不等;此外,该值仅基于系统的物理价格。此外,维护和服务成本增加了药房自动化系统的总成本。自动点胶系统需要定期更新软件才能正常运行,这是一个昂贵的过程。由于存在交叉污染的风险,药房业主常常担心配药的安全性和准确性。由于机器被编程为管理不同的药物,因此机器人中可能会残留药物的微小痕迹。因此,必须定期彻底清洁,以避免交叉污染。医疗保健专业人员需要对这些系统进行编程,药物输入中的任何错误都可能导致用药错误,影响患者的整体健康。此外,这些系统无法自行补充药物;操作员必须能够检查库存是否充足。因此,与自动配药系统相关的高资本要求和运营限制阻碍了门诊中央履行市场的增长。

细分分析:

根据产品类型,门诊中央履行市场是分为自动化配药系统、自动化包装贴标系统、自动化桌面柜台、自动化存取系统等类型。自动配药系统领域在 2022 年占据最大的门诊中央履行市场份额,预计 2022 年至 2030 年复合年增长率最高,为 12.0%。自动药物分配系统或自动药物柜是一种主要用于医疗机构中药物存储和分配的电子设备。这些系统通过经过验证的密码和生物识别技术进行药品库存控制和安全保护,有助于跟踪和控制药品分发。这些系统现已广泛应用于许多医院、诊所和疗养院。 BD 提供的 Pyxis MedStation 系统是世界上最常用的自动分配系统之一。它支持分散式药物管理,其条形码扫描可确保准确的药物配药。

根据最终用户,门诊中央履行市场分为医院药房、零售药房和邮购药房。 2022 年,医院药房领域占据了最大的门诊中央履行市场份额。预计该领域的市场在 2022 年至 2030 年期间将以最高复合年增长率增长。许多医院采用药房自动化系统来确保准确性、可重复性和患者安全。一些研究发现医院药房的人工错误率高达 10%。许多研究证明,使用 ADM 带来的好处多于责任。 2020 年 3 月,瑞仕格医疗保健与 PipelineRx 和 Savioke 合作推出了 Meds-to-Beds 计划,该计划旨在为出院时的医院门诊药房提供服务。该计划包括自动机器人交付处方药物以及扩大药房容量的咨询。由于医院药房认识到需要为患者提供高标准的护理,因此在预测期内对自动化设备的需求可能会大幅增加。

区域分析:

北美是门诊中央履行市场的主导区域。 2022年北美门诊中央履行市场预测价值为1.5256亿美元,预计到2030年将达到3.505亿美元;预计 2022 年至 2030 年复合年增长率为 11.0%。北美门诊中央履行市场分为美国、加拿大和墨西哥。该地区门诊中央履行市场的增长归因于美国越来越多地采用药房自动化、公众健康意识的提高、政府战略举措的激增以及领先药房自动化供应商的存在。美国是北美门诊中央履行市场的最大贡献者。随着药房负担的日益加重,该国用药错误的频率也随之增加。美国门诊中央履行市场份额主要归因于医疗专业人员对用药错误激增和药品需求增加的担忧。 Capsa Healthcare 总部位于美国波特兰,专注于开发药物推车、电脑推车、医疗推车、壁挂式工作站和处方药柜台。 2023年7月,公司收购了MASS Medical Storage。收购 MASS Medical Storage 为 Capsa 提供了制造医疗存储和内窥镜柜干燥系统的专业知识。 2021 年,Rx Billing Genie, LP 推出了 Rx Billing Genie 应用程序。该公司与加拿大药剂师协会的合作推动了 Rx Billing Genie 应用程序在全国范围内的采用。在墨西哥,不断增长的医疗旅游业导致药品处方激增,为门诊中央履行市场提供了重要的增长机会。

欧洲拥有第二大门诊中央履行市场份额。该地区在全球门诊中心履行市场中占有相当大的份额。众多国内市场参与者的存在和慢性病发病率的增加是有利于该地区市场的突出因素。德国是全球门诊中心履行市场的主要贡献者之一。该国拥有许多致力于医疗设备以及医疗保健行业所需配件的开发和制造的企业。此外,法国、西班牙、意大利、爱尔兰和荷兰的医疗保健行业正在以更快的速度发展,展示出创新医疗处方和配药技术的逐步使用。

亚太地区门诊中央履行市场预计 2022 年至 2030 年复合年增长率最高可达 12.1%。促进该地区市场进步的因素包括国际参与者进入医疗保健市场以及老年人口的增加。此外,传染病和慢性病病例的激增以及政府和非政府组织的举措推动了亚太地区门诊中央履行市场的增长。医疗旅游进一步促进了亚太地区医院行业的激增,进而引发了用药错误的发生率。 LEK Consulting 发布的一项调查显示,亚洲国家约 65% 的医院增加了数字化支出,以减少用药错误。

主要参与者分析:

Capsa Healthcare、Cardinal Health、 Surescripts、McKesson Corporation、Tension Packaging and Automation、ScriptPro LLC、Omnicell、BD、RxSafe LLC 和 Custom Health Inc. 是市场研究期间分析的主要门诊中心履行参与者。由于其多元化的产品组合,Capsa Healthcare 和 Omnicell 是门诊中央履行市场的两大参与者。

最新动态:

门诊中央履行市场的公司重点采用无机和有机产品策略。下面列出了近期的一些关键市场动态:

2023 年 6 月,康德乐 (Cardinal Health Inc.) 宣布计划在南卡罗来纳州格林维尔扩建一个新的配送中心。新中心将支持其家庭解决方案业务,该业务提供家庭保健医疗用品,并满足美国患有慢性和严重健康问题的人们的需求。这个新设施中心将是该公司第二个配备瑞仕格支持的 AutoStore 的配送中心,这是市场上每平方英尺最快的订单履行系统。 2023 年 11 月,Omnicell Inc 宣布肯塔基州 Baptist Health 选择了 Omnicell 的中央药房配药服务解决劳工问题,提高临床和经济效益。 Baptist Health 是最新实施 Omnicell Inc 提供的这项服务的卫生系统之一。为了提供这项服务,该公司使用先进的机器人技术、配药优化工具以及远程和现场专家来简化工作流程、提高安全性并提高配药准确性。该服务下启用的全包系统可以通过自动化和简化药房劳动力和工作流程,将药剂师的配药时间平均减少 75%。 2022 年 10 月,Omnicell Inc 宣布推出专业药房服务。这些服务致力于建立、运营和优化专业药房计划。专业药房服务是一项完整的计划,旨在协助医疗机构建立和维护医院拥有的、全面管理的专业药房。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is outpatient central fulfillment?

Automating the mechanical procedures of any pharmacy process typically entails tracking and updating customer information in databases (e.g., medical history and drug interaction risk detection), counting small objects (e.g., pills and capsules), and measuring and combining powders and fluids for compilation and other such activities. As a result, automated pharmacies are preferred by many hospitals and pharmacies. The pharmacy automation industry is growing due to increased consumer demand for pharmaceutical products, intensified competition among pharmaceutical companies, technological advancements, and precise robotic equipment availability. The increasing demand for error-free medicines is expected to drive the outpatient central fulfillment market. However, stringent regulatory control, high capital requirements, and problems associated with automation system operations limit the growth of the outpatient central fulfillment market.

What are the driving factors for the outpatient central fulfillment market across the globe?

Key factors that are driving the growth of this market are automation in pharmacies and risk of medication errors.

What is the market CAGR value of outpatient central fulfillment market during forecast period?

The CAGR value of the outpatient central fulfillment market during the forecasted period of 2022-2030 is 11.3%.

Which product type segment leads the outpatient central fulfillment market?

The automated medication dispensing systems segment held the largest share of the market in the global outpatient central fulfillment market and held the largest market share of 32.8% in 2022.

Which end user held the largest share in the outpatient central fulfillment market?

The hospital pharmacies segment dominated the global outpatient central fulfillment market and held the largest market share of 54.4% in 2022.

Who are the key players in the outpatient central fulfillment market?

The outpatient central fulfillment market majorly consists of the players such Capsa Healthcare, Cardinal Health, Surescripts, McKesson Corporation, Tension Packaging and Automation, ScriptPro LLC, Omnicell, BD, RxSafe LLC, and Custom Health Inc.

Which are the top companies that hold the market share in outpatient central fulfillment market?

Capsa Healthcare and Omnicell are the top two companies that hold huge market shares in the outpatient central fulfillment market.

Which region is expected to witness significant demand for outpatient central fulfillment market in the coming years?

Global outpatient central fulfillment market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North America regional market is expected to grow with a CAGR of 11.0% during 2022–2030. Market growth in this region is attributed to the increasing adoption of pharmacy automation in the US, rising public health awareness, surge in strategic initiatives by governments, and the presence of leading pharmacy automation vendors. The US is the largest contributor to the outpatient central fulfillment market in North America. With the growing burden on pharmacies, the frequency of medication errors also increases in the country. Thus, the outpatient central fulfillment market growth in the US is mainly attributed to rising concerns among medical professionals with an upsurge in medication errors and an increasing demand for pharmaceutical products. The Asia Pacific outpatient central fulfillment market is expected to grow at the highest CAGR of 12.1% during 2022–2030. The factors contributing to the market progress in this region include the entry of international players in healthcare markets and the increasing geriatric population.

The List of Companies - Outpatient Central Fulfillment Market

  1. Capsa Healthcare
  2. Cardinal Health
  3. Surescripts
  4. McKesson Corporation
  5. Tension Packaging and Automation
  6. ScriptPro LLC
  7. Omnicell
  8. BD
  9. RxSafe LLC
  10. Custom Health Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports